(3-Bromopropyl)benzene → HCID 66932374, compound
Reaction equation
BrC[CH2:3][CH2:4][C:5]1[CH:10]=[CH:9][CH:8]=[CH:7][CH:6]=1.[CH3:11][O:12][C:13](=[O:39])/[CH:14]=[CH:15]/[C:16]1[CH:17]=[C:18]2[C:35](=[CH:36][CH:37]=1)[O:34][C:21]1([CH2:26][CH2:25][N:24]([C:27](OC(C)(C)C)=O)[CH2:23][CH2:22]1)[CH2:20][C:19]2=[O:38]>C(Cl)Cl>[CH3:11][O:12][C:13](=[O:39])/[CH:14]=[CH:15]/[C:16]1[CH:17]=[C:18]2[C:35](=[CH:36][CH:37]=1)[O:34][C:21]1([CH2:26][CH2:25][N:24]([CH2:27][CH2:3][CH2:4][C:5]3[CH:10]=[CH:9][CH:8]=[CH:7][CH:6]=3)[CH2:23][CH2:22]1)[CH2:20][C:19]2=[O:38]Participants
4
Procedure
TEA (0.185 ml, 1.33 mmol) and (3-bromopropyl)benzene (0.134 ml, 0.88 mmol) were added to a suspension of (E)-3-{4-oxo-spiro[chromane-2,4′-piperidine]-6-yl}-acrylic acid methyl ester hydrochloride (150 mg, 0.44 mmol, Intermediate 1) in DCM (3 ml), and the mixture was stirred at RT for 24 h and then under reflux for 18 h. The solvent was removed and the crude mixture was purified by column chromatography (eluent: DCM/MeOH 97:3) to give (E)-3-{1′-(3-phenyl-propyl)-4-oxo-spiro[chromane-2,4′-piperidine]-6-yl}-acrylic acid methyl ester (173 mg) as a yellow oil.
Workup
- temperatureunder reflux for 18 h
- customThe solvent was removed
- customthe crude mixture was purified by column chromatography (eluent: DCM/MeOH 97:3)
Sources & evidence
- ORD record
- ord-f302e8f1e333438b94233c07fa857bf5
- Source dataset
- uspto-grants-2015_08
- Patent number
- US09115148B2
Reaction notes
Loading…